245 related articles for article (PubMed ID: 19410035)
1. Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double-blind, placebo-controlled multicenter trial.
Nøjgaard C; Hornum M; Elkjaer M; Hjalmarsson C; Heyries L; Hauge T; Bakkevold K; Andersen PK; Matzen P;
Gastrointest Endosc; 2009 May; 69(6):e31-7. PubMed ID: 19410035
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis.
Kaffes AJ; Bourke MJ; Ding S; Alrubaie A; Kwan V; Williams SJ
Gastrointest Endosc; 2006 Sep; 64(3):351-7. PubMed ID: 16923481
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
[TBL] [Abstract][Full Text] [Related]
4. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
5. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial.
Beauchant M; Ingrand P; Favriel JM; Dupuychaffray JP; Capony P; Moindrot H; Barthet M; Escourrou J; Plane C; Barrioz T; Lacoste L; Ingrand I
Endoscopy; 2008 Aug; 40(8):631-6. PubMed ID: 18680075
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
Sudhindran S; Bromwich E; Edwards PR
Br J Surg; 2001 Sep; 88(9):1178-82. PubMed ID: 11531863
[TBL] [Abstract][Full Text] [Related]
8. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.
Sotoudehmanesh R; Khatibian M; Kolahdoozan S; Ainechi S; Malboosbaf R; Nouraie M
Am J Gastroenterol; 2007 May; 102(5):978-83. PubMed ID: 17355281
[TBL] [Abstract][Full Text] [Related]
11. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial.
Dumot JA; Conwell DL; O'Connor JB; Ferguson DR; Vargo JJ; Barnes DS; Shay SS; Sterling MJ; Horth KS; Issa K; Ponsky JL; Zuccaro G
Am J Gastroenterol; 1998 Jan; 93(1):61-5. PubMed ID: 9448176
[TBL] [Abstract][Full Text] [Related]
14. Allopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial.
Romagnuolo J; Hilsden R; Sandha GS; Cole M; Bass S; May G; Love J; Bain VG; McKaigney J; Fedorak RN
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):465-71; quiz 371. PubMed ID: 18304883
[TBL] [Abstract][Full Text] [Related]
15. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Bai Y; Xu C; Yang X; Gao J; Zou DW; Li ZS
Endoscopy; 2009 Aug; 41(8):690-5. PubMed ID: 19670137
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial.
Cheon YK; Cho KB; Watkins JL; McHenry L; Fogel EL; Sherman S; Schmidt S; Lazzell-Pannell L; Lehman GA
Gastrointest Endosc; 2007 Dec; 66(6):1126-32. PubMed ID: 18061712
[TBL] [Abstract][Full Text] [Related]
18. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
[TBL] [Abstract][Full Text] [Related]
19. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.
Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM
Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
